跳至主要内容
临床试验/NCT02818179
NCT02818179Unknown不适用

Monitoring HDR Brachytherapy for Cervical Cancer by Optic and Thermal Imaging

Sheba Medical Center0 个研究点目标入组 100 人开始时间: 2016年12月最近更新:
适应症

试验速览

阶段
不适用
入组人数
100
主要终点
The change in Infra-Red radiation emitted at wavelengths 0.8-1nm

研究概览

简要总结

This research aims to investigate the correlation between tumor temperature difference and biological factors, such as size, metabolism, treatment response, and tumor aggressiveness.

In addition, normal tissue response to radiation therapy in treated organ will be evaluated.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
盲法
None

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • signed informed consent
  • biopsy proven cervical cancer which will undergo definitive radiation

排除标准

  • not eligible to sign informed consent

结局指标

主要结局

The change in Infra-Red radiation emitted at wavelengths 0.8-1nm

时间窗: Baseline and 4 weeks

Measurement of IR

次要结局

  • Evaluating of efficacy of the radiation(3 months after the treatment)

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Dr. Tatiana Rabin MD

Senior Medical Doctor

Sheba Medical Center

相似试验